What is the net worth of Moderna owners? Meet the new billionaires, thanks to the Covid vaccine

0


[ad_1]

The Covid-19 pandemic has been hell for many people. From job losses to rent problems, millions of Americans have found themselves poorer as a result of the pandemic. But a select group of Americans (the 400 richest Americans) saw their collective wealth grow by more than 40%, including the founders of Moderna. The two men behind the biotech giant and their original investor are now worth billions and are on Forbes’ list of the 400 richest Americans.

At the heart of this growth is the Moderna Covid vaccine, which, as of November 2020, was 100% effective against serious illnesses. The Cambridge, Massachusetts-based company was the first to start testing its vaccine in human patients and has since become a key player in the international vaccine market. With billions of doses shipped, the company appears to have experienced a healthy rise in its stock price during the pandemic.

RELATED ARTICLES

Why don’t the names of Jeff Bezos, Elon Musk or Bill Gates appear in the Pandora Papers leak?

What is Denny Sanford’s net worth? Billionaire offers $ 350 million in child pornography scandal

On October 7, 2020, the Moderna share price was $ 73.37. Exactly one year later, it is now worth $ 302.42. This massive increase, over 300%, also helped the three men behind the business. Meet the new American billionaires – the founders of Moderna, Noubar Afeyan and Robert Langer, and investor Timothy Springer.

A screenshot of the Moderna share price over the past year.

Noubar Afeyan net worth

The 59-year-old American-Canadian entrepreneur is a very wealthy man, and it’s not just because of Moderna. A graduate of McGill University and MIT, Afeyan has helped start more than 70 life science and technology companies over the past decades. These include Flagship Pioneering, PerSeptive Biosystems, Chemgenics Pharmaceuticals and Affinnova. He also owns shares in 12 publicly traded companies, including Moderna.

As a result, Afeyan has amassed a huge fortune over the past decades. It is now worth $ 3.7 billion and ranks 212 on the Forbes list. A majority of that wealth comes from the millions of stock units he holds at Moderna, would have valued over $ 3 billion. On top of that, he earns $ 530,000 per year as CEO of Moderna.

Moderna CEO and co-founder Noubar Afeyan. (Noubar Afeyan / Twitter)

Robert Langer net worth

Moderna’s second co-founder has an equally impressive CV. After degrees from Cornell and MIT, Langer worked as a cancer researcher. He is well regarded as a biotechnology pioneer and is considered “the most cited engineer in history”. He would have about 350,000 citations and over 1,500 published articles. On top of that, he also owns over 1,400 patents and patent applications, many of which are licensed to other companies.

Langer has also been involved in the founding of more than 20 biotechnology companies, many of which are shareholders. But Moderna is the most valuable. His 3% stake in the company alone is now worth more than $ 1 billion, giving him a total net worth of $ 3.5 billion. It also helps that he works alongside MIT and also runs the Langer research lab at the university, which is one of the largest biomedical engineering labs in the world.

Co-founder of Moderna and professor at MIT, Robert Langer. (Langer Lab / MIT website)

Timothy Springer Net Worth

An immunologist and professor at Harvard Medical School, Springer invested $ 5 million in Moderna in 2010. Most of that money comes from other companies he founded or in which he has invested, such as Selecta Biosciences, Morphic Therapeutic and Scholar Rock. He also made $ 100 million on his first LeukoSite business, which he sold in 1999. But all of those investments pale in comparison to his Moderna.

When he invested, Springer became Moderna’s fourth largest shareholder and earned $ 400 million from the company’s IPO. Now, thanks to the pandemic, he’s worth $ 4.4 billion, all of which has been accumulated from the various biotech companies he’s invested in. But his 3.5% stake in Moderna alone is worth a hefty fortune, around $ 870 million. according to Forbes. Like Langer and Afeyan, Springer isn’t too big on his wealth. The three men make large donations to charity and maintain a very low key lifestyle.

Timothy Springer, professor at Harvard and investor in Moderna. (Harvard University)

That said, there is no denying that they have managed to make the most of the pandemic. They were added to Forbes’ list of the 400 richest Americans on October 5, based on records available from September. As for Moderna itself, the business just continues to grow and grow. On August 9, 2021, the company’s stock hit a record high of $ 484.47. While it has fallen since then, it is still worth a lot, and all thanks to Moderna’s Covid-19 vaccine which has quickly become an essential element in the fight against the pandemic.

If you have a scoop or an interesting story for us, please contact us at (323) 421-7514

[ad_2]

Leave A Reply

Your email address will not be published.